(Q33318669)

25 July 2017

title

Quantitative analysis of a panel of gene expression in prostate cancer--with emphasis on NPY expression analysis (English)

1 reference

25 July 2017

Bungo Furusato

2

0 references

author name string

Ai-jun Liu

1

1 reference

25 July 2017

Lakshmi Ravindranath

3

1 reference

25 July 2017

Yong-mei Chen

4

1 reference

25 July 2017

Vasanta Srikantan

5

1 reference

25 July 2017

David G McLeod

6

1 reference

25 July 2017

Gyorgy Petrovics

7

1 reference

25 July 2017

Shiv Srivastava

8

1 reference

25 July 2017

publication date

1 December 2007

1 reference

Journal of Zhejiang University. Science. B

25 July 2017

published in

1 reference

25 July 2017

volume

8

1 reference

25 July 2017

issue

12

1 reference

25 July 2017

page(s)

853-859

1 reference

FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.

25 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100155

Modulatory actions of neuropeptide Y on prostate cancer growth: role of MAP kinase/ERK 1/2 activation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100155

Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100155

21 June 2018

Cancer statistics, 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100155

Expression of human telomerase reverse transcriptase, Survivin, DD3 and PCGEM1 messenger RNA in archival prostate carcinoma tissue

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100155

Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100155

Carcinoma of the prostate: inherited susceptibility, somatic gene defects and androgen receptors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100155

Molecular markers to identify patients at risk for recurrence after primary treatment for prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100155

Molecular determinants of resistance to antiandrogen therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100155

Neuropeptide Y and its receptors as potential therapeutic drug targets

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100155

Combined-modality staging for localized adenocarcinoma of the prostate.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100155

Gene expression of adrenomedullin, leptin, their receptors and neuropeptide Y in hormone-secreting and non-functioning pituitary adenomas, meningiomas and malignant intracranial tumours in humans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100155

Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100155

Aberrant Neuropeptide Y and Macrophage Inhibitory Cytokine-1 Expression Are Early Events in Prostate Cancer Development and Are Associated with Poor Prognosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100155

Gene expression correlates of clinical prostate cancer behavior

31 October 2018

1 reference

12 December 2020

Vasoactive intestinal polypeptide (VIP) and neuropeptide tyrosine (NPY) in prostate carcinoma

1 reference

12 December 2020

Heterogeneous expression of ?-methylacyl-CoA racemase in prostatic cancer correlates with Gleason score

1 reference

12 December 2020

Role of PTEN gene in progression of prostate cancer

1 reference

12 December 2020

Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets

1 reference

12 December 2020

Identifiers

DOI

10.1631/JZUS.2007.B0853

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference